3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
6
Prostatic Neoplasms
5
Neoplasms
5
Multiple Myeloma
4
Neoplasms, Plasma Cell
3
Colorectal Neoplasms
3
Hematologic Neoplasms
2
Frailty
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Upper Excretory Tract Tumors
1
Transfusion-Related Acute Lung Injury
1
Thrombosis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Sleep Initiation and Maintenance Disorders
1
Sleep Disorders, Circadian Rhythm
1
Sezary Syndrome
1
Sarcopenia
1
Sarcoglycanopathies
1
Psoriasis
1
Peripheral Arterial Disease
1
Patient Acceptance of Health Care
1
Ovarian Neoplasms
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Mycoses
1
Melanoma
1
Malnutrition
1
Interventions
Liquid Biopsy
4
Blood Specimen Collection
4
Gemcitabine
3
pembrolizumab
2
Immunohistochemistry
2
Cisplatin
2
Capecitabine
2
Base Sequence
2
130-nm albumin-bound paclitaxel
2
tislelizumab
1
taxane
1
lenvatinib
1
irinotecan sucrosofate
1
gemcitabine-oxaliplatin regimen
1
Tegafur
1
Taxes
1
Surgical Procedures, Operative
1
Standard of Care
1
S 1 (combination)
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Oxaliplatin
1
Nivolumab
1
Microscopy, Confocal
1
Methylation
1
Mass Spectrometry
1
Leucovorin
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
High-Throughput Nucleotide Sequencing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Biliary Tract Neoplasms
×
Standard of Care
×
Clear all
NCT07184047
2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
72 enrolled